These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19042205)

  • 1. Pharmacotherapy of methamphetamine addiction: an update.
    Elkashef A; Vocci F; Hanson G; White J; Wickes W; Tiihonen J
    Subst Abus; 2008; 29(3):31-49. PubMed ID: 19042205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of amphetamine-type stimulant dependence: an update.
    Brensilver M; Heinzerling KG; Shoptaw S
    Drug Alcohol Rev; 2013 Sep; 32(5):449-60. PubMed ID: 23617468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for methamphetamine abuse: a literature review for the clinician.
    Brackins T; Brahm NC; Kissack JC
    J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine Use: A New Wave in the Opioid Crisis?
    Fogger SA
    J Addict Nurs; 2019; 30(3):219-223. PubMed ID: 31478970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches to methamphetamine dependence: a focused review.
    Karila L; Weinstein A; Aubin HJ; Benyamina A; Reynaud M; Batki SL
    Br J Clin Pharmacol; 2010 Jun; 69(6):578-92. PubMed ID: 20565449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.
    Tiihonen J; Kuoppasalmi K; Föhr J; Tuomola P; Kuikanmäki O; Vorma H; Sokero P; Haukka J; Meririnne E
    Am J Psychiatry; 2007 Jan; 164(1):160-2. PubMed ID: 17202560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.
    Rose ME; Grant JE
    Ann Clin Psychiatry; 2008; 20(3):145-55. PubMed ID: 18633741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
    Herin DV; Rush CR; Grabowski J
    Ann N Y Acad Sci; 2010 Feb; 1187():76-100. PubMed ID: 20201847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.
    Schwienteck KL; Banks ML
    Drug Alcohol Depend; 2015 Oct; 155():16-23. PubMed ID: 26361713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.